News & Views

The choices in the drug development model to navigate clinical pathways, and the relationship between drug developers and CROs/ CDMOs can be incredibly complex...
Louis Garguilo, Chief Editor, Outsourced Pharma, has published the latest part of his interview with Ali Pashazadeh, CEO, Treehill where Ali details why we think biopharmas and outsourced providers need strategic help to focus more on profitability...
"How do you act as a good corporate citizen and disclose, without jeopardizing the unknown?"...
As the BIO International 2024 trade show approaches, industry insiders anticipate a significant focus on partnership discussions, driven by the pressing financial needs of biotech companies...